Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Return on Sales (2016 - 2025)

Historic Return on Sales for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to 4.92%.

  • Ocular Therapeutix's Return on Sales fell 20600.0% to 4.92% in Q4 2025 from the same period last year, while for Dec 2025 it was 5.07%, marking a year-over-year decrease of 24800.0%. This contributed to the annual value of 5.07% for FY2025, which is 24800.0% down from last year.
  • As of Q4 2025, Ocular Therapeutix's Return on Sales stood at 4.92%, which was down 20600.0% from 4.67% recorded in Q3 2025.
  • Over the past 5 years, Ocular Therapeutix's Return on Sales peaked at 1.42% during Q3 2023, and registered a low of 5.9% during Q1 2025.
  • In the last 5 years, Ocular Therapeutix's Return on Sales had a median value of 1.9% in 2021 and averaged 2.59%.
  • Per our database at Business Quant, Ocular Therapeutix's Return on Sales skyrocketed by 106000bps in 2021 and then tumbled by -37500bps in 2025.
  • Over the past 5 years, Ocular Therapeutix's Return on Sales (Quarter) stood at 1.6% in 2021, then grew by 8bps to 1.48% in 2022, then dropped by -4bps to 1.54% in 2023, then plummeted by -87bps to 2.87% in 2024, then tumbled by -72bps to 4.92% in 2025.
  • Its Return on Sales was 4.92% in Q4 2025, compared to 4.67% in Q3 2025 and 4.99% in Q2 2025.